Cargando…

A poised fragment library enables rapid synthetic expansion yielding the first reported inhibitors of PHIP(2), an atypical bromodomain

Research into the chemical biology of bromodomains has been driven by the development of acetyl-lysine mimetics. The ligands are typically anchored by binding to a highly conserved asparagine residue. Atypical bromodomains, for which the asparagine is mutated, have thus far proven elusive targets, i...

Descripción completa

Detalles Bibliográficos
Autores principales: Cox, Oakley B., Krojer, Tobias, Collins, Patrick, Monteiro, Octovia, Talon, Romain, Bradley, Anthony, Fedorov, Oleg, Amin, Jahangir, Marsden, Brian D., Spencer, John, von Delft, Frank, Brennan, Paul E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Royal Society of Chemistry 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5977933/
https://www.ncbi.nlm.nih.gov/pubmed/29910922
http://dx.doi.org/10.1039/c5sc03115j
_version_ 1783327435206426624
author Cox, Oakley B.
Krojer, Tobias
Collins, Patrick
Monteiro, Octovia
Talon, Romain
Bradley, Anthony
Fedorov, Oleg
Amin, Jahangir
Marsden, Brian D.
Spencer, John
von Delft, Frank
Brennan, Paul E.
author_facet Cox, Oakley B.
Krojer, Tobias
Collins, Patrick
Monteiro, Octovia
Talon, Romain
Bradley, Anthony
Fedorov, Oleg
Amin, Jahangir
Marsden, Brian D.
Spencer, John
von Delft, Frank
Brennan, Paul E.
author_sort Cox, Oakley B.
collection PubMed
description Research into the chemical biology of bromodomains has been driven by the development of acetyl-lysine mimetics. The ligands are typically anchored by binding to a highly conserved asparagine residue. Atypical bromodomains, for which the asparagine is mutated, have thus far proven elusive targets, including PHIP(2) whose parent protein, PHIP, has been linked to disease progression in diabetes and cancers. The PHIP(2) binding site contains a threonine in place of asparagine, and solution screening have yielded no convincing hits. We have overcome this hurdle by combining the sensitivity of X-ray crystallography, used as the primary fragment screen, with a strategy for rapid follow-up synthesis using a chemically-poised fragment library, which allows hits to be readily modified by parallel chemistry both peripherally and in the core. Our approach yielded the first reported hit compounds of PHIP(2) with measurable IC(50) values by an AlphaScreen competition assay. The follow-up libraries of four poised fragment hits improved potency into the sub-mM range while showing good ligand efficiency and detailed structural data.
format Online
Article
Text
id pubmed-5977933
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Royal Society of Chemistry
record_format MEDLINE/PubMed
spelling pubmed-59779332018-06-15 A poised fragment library enables rapid synthetic expansion yielding the first reported inhibitors of PHIP(2), an atypical bromodomain Cox, Oakley B. Krojer, Tobias Collins, Patrick Monteiro, Octovia Talon, Romain Bradley, Anthony Fedorov, Oleg Amin, Jahangir Marsden, Brian D. Spencer, John von Delft, Frank Brennan, Paul E. Chem Sci Chemistry Research into the chemical biology of bromodomains has been driven by the development of acetyl-lysine mimetics. The ligands are typically anchored by binding to a highly conserved asparagine residue. Atypical bromodomains, for which the asparagine is mutated, have thus far proven elusive targets, including PHIP(2) whose parent protein, PHIP, has been linked to disease progression in diabetes and cancers. The PHIP(2) binding site contains a threonine in place of asparagine, and solution screening have yielded no convincing hits. We have overcome this hurdle by combining the sensitivity of X-ray crystallography, used as the primary fragment screen, with a strategy for rapid follow-up synthesis using a chemically-poised fragment library, which allows hits to be readily modified by parallel chemistry both peripherally and in the core. Our approach yielded the first reported hit compounds of PHIP(2) with measurable IC(50) values by an AlphaScreen competition assay. The follow-up libraries of four poised fragment hits improved potency into the sub-mM range while showing good ligand efficiency and detailed structural data. Royal Society of Chemistry 2016-03-01 2015-12-22 /pmc/articles/PMC5977933/ /pubmed/29910922 http://dx.doi.org/10.1039/c5sc03115j Text en This journal is © The Royal Society of Chemistry 2016 http://creativecommons.org/licenses/by/3.0/ This article is freely available. This article is licensed under a Creative Commons Attribution 3.0 Unported Licence (CC BY 3.0)
spellingShingle Chemistry
Cox, Oakley B.
Krojer, Tobias
Collins, Patrick
Monteiro, Octovia
Talon, Romain
Bradley, Anthony
Fedorov, Oleg
Amin, Jahangir
Marsden, Brian D.
Spencer, John
von Delft, Frank
Brennan, Paul E.
A poised fragment library enables rapid synthetic expansion yielding the first reported inhibitors of PHIP(2), an atypical bromodomain
title A poised fragment library enables rapid synthetic expansion yielding the first reported inhibitors of PHIP(2), an atypical bromodomain
title_full A poised fragment library enables rapid synthetic expansion yielding the first reported inhibitors of PHIP(2), an atypical bromodomain
title_fullStr A poised fragment library enables rapid synthetic expansion yielding the first reported inhibitors of PHIP(2), an atypical bromodomain
title_full_unstemmed A poised fragment library enables rapid synthetic expansion yielding the first reported inhibitors of PHIP(2), an atypical bromodomain
title_short A poised fragment library enables rapid synthetic expansion yielding the first reported inhibitors of PHIP(2), an atypical bromodomain
title_sort poised fragment library enables rapid synthetic expansion yielding the first reported inhibitors of phip(2), an atypical bromodomain
topic Chemistry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5977933/
https://www.ncbi.nlm.nih.gov/pubmed/29910922
http://dx.doi.org/10.1039/c5sc03115j
work_keys_str_mv AT coxoakleyb apoisedfragmentlibraryenablesrapidsyntheticexpansionyieldingthefirstreportedinhibitorsofphip2anatypicalbromodomain
AT krojertobias apoisedfragmentlibraryenablesrapidsyntheticexpansionyieldingthefirstreportedinhibitorsofphip2anatypicalbromodomain
AT collinspatrick apoisedfragmentlibraryenablesrapidsyntheticexpansionyieldingthefirstreportedinhibitorsofphip2anatypicalbromodomain
AT monteirooctovia apoisedfragmentlibraryenablesrapidsyntheticexpansionyieldingthefirstreportedinhibitorsofphip2anatypicalbromodomain
AT talonromain apoisedfragmentlibraryenablesrapidsyntheticexpansionyieldingthefirstreportedinhibitorsofphip2anatypicalbromodomain
AT bradleyanthony apoisedfragmentlibraryenablesrapidsyntheticexpansionyieldingthefirstreportedinhibitorsofphip2anatypicalbromodomain
AT fedorovoleg apoisedfragmentlibraryenablesrapidsyntheticexpansionyieldingthefirstreportedinhibitorsofphip2anatypicalbromodomain
AT aminjahangir apoisedfragmentlibraryenablesrapidsyntheticexpansionyieldingthefirstreportedinhibitorsofphip2anatypicalbromodomain
AT marsdenbriand apoisedfragmentlibraryenablesrapidsyntheticexpansionyieldingthefirstreportedinhibitorsofphip2anatypicalbromodomain
AT spencerjohn apoisedfragmentlibraryenablesrapidsyntheticexpansionyieldingthefirstreportedinhibitorsofphip2anatypicalbromodomain
AT vondelftfrank apoisedfragmentlibraryenablesrapidsyntheticexpansionyieldingthefirstreportedinhibitorsofphip2anatypicalbromodomain
AT brennanpaule apoisedfragmentlibraryenablesrapidsyntheticexpansionyieldingthefirstreportedinhibitorsofphip2anatypicalbromodomain
AT coxoakleyb poisedfragmentlibraryenablesrapidsyntheticexpansionyieldingthefirstreportedinhibitorsofphip2anatypicalbromodomain
AT krojertobias poisedfragmentlibraryenablesrapidsyntheticexpansionyieldingthefirstreportedinhibitorsofphip2anatypicalbromodomain
AT collinspatrick poisedfragmentlibraryenablesrapidsyntheticexpansionyieldingthefirstreportedinhibitorsofphip2anatypicalbromodomain
AT monteirooctovia poisedfragmentlibraryenablesrapidsyntheticexpansionyieldingthefirstreportedinhibitorsofphip2anatypicalbromodomain
AT talonromain poisedfragmentlibraryenablesrapidsyntheticexpansionyieldingthefirstreportedinhibitorsofphip2anatypicalbromodomain
AT bradleyanthony poisedfragmentlibraryenablesrapidsyntheticexpansionyieldingthefirstreportedinhibitorsofphip2anatypicalbromodomain
AT fedorovoleg poisedfragmentlibraryenablesrapidsyntheticexpansionyieldingthefirstreportedinhibitorsofphip2anatypicalbromodomain
AT aminjahangir poisedfragmentlibraryenablesrapidsyntheticexpansionyieldingthefirstreportedinhibitorsofphip2anatypicalbromodomain
AT marsdenbriand poisedfragmentlibraryenablesrapidsyntheticexpansionyieldingthefirstreportedinhibitorsofphip2anatypicalbromodomain
AT spencerjohn poisedfragmentlibraryenablesrapidsyntheticexpansionyieldingthefirstreportedinhibitorsofphip2anatypicalbromodomain
AT vondelftfrank poisedfragmentlibraryenablesrapidsyntheticexpansionyieldingthefirstreportedinhibitorsofphip2anatypicalbromodomain
AT brennanpaule poisedfragmentlibraryenablesrapidsyntheticexpansionyieldingthefirstreportedinhibitorsofphip2anatypicalbromodomain